Variant report

Variant	esv3375546
Chromosome Location	chr2:153190731-153193579
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:695)
CpG islands
(count:734)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:695 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:153191240-153191859	HepG2	liver:	n/a	chr2:153191336-153191352
2	ATF1	chr2:153191350-153191703	K562	blood:	n/a	n/a
3	ATF2	chr2:153191509-153191860	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr2:153191374-153191726	K562	blood:	n/a	chr2:153191520-153191528
5	BACH1	chr2:153192492-153192606	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr2:153192462-153192566	HepG2	liver:	n/a	n/a
7	BHLHE40	chr2:153191523-153192773	GM12878	blood:	n/a	chr2:153191746-153191762 chr2:153191749-153191765 chr2:153192452-153192468 chr2:153192032-153192048 chr2:153191744-153191760 chr2:153192038-153192054
8	BRCA1	chr2:153191406-153191854	Hela-S3	cervix:	n/a	n/a
9	CBX3	chr2:153191260-153191698	K562	blood:	n/a	n/a
10	CCNT2	chr2:153191470-153192389	K562	blood:	n/a	chr2:153192303-153192312 chr2:153192298-153192307
11	CCNT2	chr2:153192704-153192820	K562	blood:	n/a	n/a
12	CEBPB	chr2:153191784-153191888	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr2:153193545-153193882	A549	lung:	n/a	chr2:153193700-153193711 chr2:153193699-153193712
14	CEBPB	chr2:153193524-153193889	IMR90	lung:	n/a	chr2:153193700-153193711 chr2:153193699-153193712
15	CEBPB	chr2:153193519-153193856	HepG2	liver:	n/a	chr2:153193700-153193711 chr2:153193699-153193712
16	CEBPB	chr2:153191388-153191688	Hela-S3	cervix:	n/a	n/a
17	CEBPD	chr2:153191392-153191831	HepG2	liver:	n/a	n/a
18	CEBPD	chr2:153191389-153191896	HepG2	liver:	n/a	n/a
19	CHD1	chr2:153191632-153192254	GM12878	blood:	n/a	n/a
20	CHD1	chr2:153192571-153193275	GM12878	blood:	n/a	n/a
21	CHD1	chr2:153191780-153192317	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD1	chr2:153193154-153193159	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr2:153191469-153191901	HepG2	liver:	n/a	n/a
24	CHD2	chr2:153191454-153191722	H1-hESC	embryonic stem cell:	n/a	n/a
25	CHD2	chr2:153192089-153192251	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr2:153191839-153191930	K562	blood:	n/a	n/a
27	CHD2	chr2:153193096-153193205	GM12878	blood:	n/a	n/a
28	CHD2	chr2:153191358-153192128	Hela-S3	cervix:	n/a	n/a
29	CHD2	chr2:153192404-153192841	GM12878	blood:	n/a	n/a
30	CHD2	chr2:153192481-153192619	H1-hESC	embryonic stem cell:	n/a	n/a
31	CHD2	chr2:153192735-153192779	HepG2	liver:	n/a	n/a
32	CHD2	chr2:153191433-153192069	GM12878	blood:	n/a	n/a
33	CHD2	chr2:153193285-153193376	HepG2	liver:	n/a	n/a
34	CREB1	chr2:153191256-153191870	H1-hESC	embryonic stem cell:	n/a	n/a
35	CREB1	chr2:153191387-153191871	GM12878	blood:	n/a	n/a
36	CREB1	chr2:153191412-153192207	A549	lung:	n/a	n/a
37	CREB1	chr2:153191189-153191959	H1-hESC	embryonic stem cell:	n/a	n/a
38	CREB1	chr2:153191215-153191969	HepG2	liver:	n/a	n/a
39	CREB1	chr2:153191206-153191949	K562	blood:	n/a	n/a
40	CREB1	chr2:153191351-153191852	K562	blood:	n/a	n/a
41	CREB1	chr2:153191241-153193852	HepG2	liver:	n/a	n/a
42	CTBP2	chr2:153191430-153193417	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr2:153191440-153191590	HMEC	breast:	n/a	n/a
44	CTCF	chr2:153192000-153192150	HUVEC	blood vessel:	n/a	n/a
45	CTCF	chr2:153191442-153191632	GM12892	blood:	n/a	n/a
46	CTCF	chr2:153191442-153191592	A549	lung:	n/a	n/a
47	CTCF	chr2:153191820-153191970	HCPEpiC	choroid plexus:	n/a	n/a
48	CTCF	chr2:153191520-153191670	HPAF	blood vessel:	n/a	n/a
49	CTCF	chr2:153191700-153191850	BJ	skin:	n/a	n/a
50	CTCF	chr2:153191679-153192216	K562	blood:	n/a	n/a

(count:734 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:153191749-153191799	AG04449	skin:	fetal
2	chr2:153191715-153191765	Jurkat	blood:	n/a
3	chr2:153191749-153191799	AG04449	skin:	fetal
4	chr2:153191715-153191765	Jurkat	blood:	n/a
5	chr2:153191532-153191582	ProgFib	skin:	n/a
6	chr2:153192164-153192214	HL-60	blood:	n/a
7	chr2:153191822-153191872	Caco-2	colon:	n/a
8	chr2:153191532-153191582	HEK293	kidney:	embryo
9	chr2:153191727-153191777	ECC-1	luminal epithelium:	n/a
10	chr2:153191822-153191872	HCF	heart:	n/a
11	chr2:153191031-153191081	Hela-S3	cervix:	n/a
12	chr2:153192532-153192582	MCF-7	breast:	n/a
13	chr2:153192532-153192582	K562	blood:	n/a
14	chr2:153191715-153191765	HIPEpiC	eye:	n/a
15	chr2:153191749-153191799	PrEC	prostate:	n/a
16	chr2:153191715-153191765	AG04449	skin:	fetal
17	chr2:153191031-153191081	H1-hESC	embryonic stem cell:	embryo
18	chr2:153192938-153192988	AG09319	gingival:	n/a
19	chr2:153192460-153192510	HIPEpiC	eye:	n/a
20	chr2:153191675-153191725	GM12891	blood:	n/a
21	chr2:153191749-153191799	U87	brain:	n/a
22	chr2:153191727-153191777	AoSMC	blood vessel:	n/a
23	chr2:153192532-153192582	HRE	kidney:	n/a
24	chr2:153192532-153192582	Caco-2	colon:	n/a
25	chr2:153191727-153191777	NT2-D1	testis:	n/a
26	chr2:153192164-153192214	NH-A	brain:	n/a
27	chr2:153191524-153191574	K562	blood:	n/a
28	chr2:153191031-153191081	HRPEpiC	eye:	n/a
29	chr2:153191675-153191725	ProgFib	skin:	n/a
30	chr2:153191727-153191777	K562	blood:	n/a
31	chr2:153191031-153191081	RPTEC	kidney:	n/a
32	chr2:153191822-153191872	HL-60	blood:	n/a
33	chr2:153191822-153191872	NH-A	brain:	n/a
34	chr2:153192532-153192582	NH-A	brain:	n/a
35	chr2:153191031-153191081	AoSMC	blood vessel:	n/a
36	chr2:153191532-153191582	SK-N-MC	brain:	n/a
37	chr2:153191675-153191725	Hepatocyte	liver:	n/a
38	chr2:153192460-153192510	PANC-1	pancreas:	n/a
39	chr2:153191675-153191725	SK-N-SH	brain:	n/a
40	chr2:153191715-153191765	SK-N-SH_RA	brain:	n/a
41	chr2:153191675-153191725	GM12878	blood:	n/a
42	chr2:153191532-153191582	HL-60	blood:	n/a
43	chr2:153191532-153191582	Hepatocyte	liver:	n/a
44	chr2:153191727-153191777	PFSK-1	brain:	n/a
45	chr2:153191749-153191799	HMEC	breast:	n/a
46	chr2:153191822-153191872	BE2_C	brain:	n/a
47	chr2:153192938-153192988	AG10803	skin:	n/a
48	chr2:153192532-153192582	Jurkat	blood:	n/a
49	chr2:153191727-153191777	HPAEpiC	pulmonary alveolar:	n/a
50	chr2:153192938-153192988	GM19239	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:153030097..153032269-chr2:153191350..153193391,2	MCF-7	breast:
2	chr2:153193156..153194815-chr2:153197354..153200252,2	MCF-7	breast:
3	chr2:153181849..153185587-chr2:153188964..153191697,3	MCF-7	breast:

No data

Variant related genes	Relation type
FMNL2	TF binding region
FMNL2	CpG island
ENSG00000115145	chromatin interactions

Extended variants
information (count: 109 )
Associated
traits (count: 52 )

Variant overlapped rSNPs/rCNVs (count:109 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs534043756	chr2:153190761-153190762	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs150017754	chr2:153190764-153190765	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs181866141	chr2:153190773-153190774	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs576955462	chr2:153190832-153190833	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs184676772	chr2:153190842-153190843	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs562552450	chr2:153190857-153190858	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs576180915	chr2:153190894-153190895	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs541964402	chr2:153190953-153190954	Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs561628440	chr2:153191005-153191006	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs527293201	chr2:153191037-153191038	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs189519458	chr2:153191075-153191076	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs564667737	chr2:153191097-153191098	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs34557031	chr2:153191110-153191111	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs397787093	chr2:153191112-153191113	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs536359470	chr2:153191124-153191125	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs145181688	chr2:153191152-153191153	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs180690456	chr2:153191167-153191168	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs138881933	chr2:153191172-153191173	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs529305702	chr2:153191191-153191192	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs368985524	chr2:153191292-153191293	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs530692651	chr2:153191370-153191371	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs114401900	chr2:153191371-153191372	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs62179527	chr2:153191399-153191400	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs141184614	chr2:153191431-153191432	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs576826692	chr2:153191449-153191450	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs145011554	chr2:153191515-153191516	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs369645575	chr2:153191546-153191547	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs570686613	chr2:153191648-153191649	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs539768378	chr2:153191653-153191654	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs10203197	chr2:153191655-153191656	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs576315369	chr2:153191684-153191685	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs376545848	chr2:153191707-153191708	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs151196856	chr2:153191720-153191721	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs555219235	chr2:153191732-153191733	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs571998897	chr2:153191781-153191782	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs540704106	chr2:153191801-153191802	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs564130255	chr2:153191845-153191846	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs10200831	chr2:153191866-153191867	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs543714764	chr2:153191875-153191876	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs374160133	chr2:153191931-153191932	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs202079133	chr2:153192094-153192095	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs529489608	chr2:153192105-153192106	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs201363558	chr2:153192170-153192171	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs566073374	chr2:153192232-153192233	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs147562333	chr2:153192242-153192243	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs551461783	chr2:153192316-153192317	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs2003332	chr2:153192324-153192325	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs35527110	chr2:153192351-153192352	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs539705469	chr2:153192359-153192360	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs374036016	chr2:153192376-153192377	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:52)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Mental retardation	22214275	CNVD
Glioblastoma	21080181	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	19156171	CNVD
Acute myeloid leukemia	18000384	CNVD
Autism	20808228	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:357 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:153187000-153191200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr2:153188800-153191200	Weak transcription	Right Atrium	heart
3	chr2:153190200-153191200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr2:153190600-153190800	Bivalent Enhancer	HepG2	liver
5	chr2:153190600-153190800	Active TSS	NHEK	skin
6	chr2:153190600-153191200	Enhancers	Fetal Stomach	stomach
7	chr2:153190800-153191000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr2:153190800-153191000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr2:153190800-153191000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr2:153190800-153191000	Enhancers	Brain Angular Gyrus	brain
11	chr2:153190800-153191000	Enhancers	Brain Hippocampus Middle	brain
12	chr2:153190800-153191000	Enhancers	Brain Inferior Temporal Lobe	brain
13	chr2:153190800-153191000	Enhancers	Brain Substantia Nigra	brain
14	chr2:153190800-153191000	Enhancers	A549	lung
15	chr2:153190800-153191200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
16	chr2:153190800-153191200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr2:153190800-153191200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr2:153190800-153191200	Enhancers	Brain Anterior Caudate	brain
19	chr2:153190800-153191200	Enhancers	Brain Cingulate Gyrus	brain
20	chr2:153190800-153191200	Enhancers	Fetal Brain Male	brain
21	chr2:153190800-153191200	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr2:153190800-153191200	Enhancers	Hela-S3	cervix
23	chr2:153190800-153191200	Enhancers	NHDF-Ad	bronchial
24	chr2:153190800-153191400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr2:153190800-153191400	Flanking Bivalent TSS/Enh	HepG2	liver
26	chr2:153190800-153191600	Flanking Active TSS	NHEK	skin
27	chr2:153190800-153192800	Active TSS	Skeletal Muscle Female	skeletal muscle
28	chr2:153191000-153191200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr2:153191000-153191200	Enhancers	iPS-18 Cell Line	embryonic stem cell
30	chr2:153191000-153191200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr2:153191000-153191200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr2:153191000-153191200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr2:153191000-153191200	Enhancers	Muscle Satellite Cultured Cells	--
34	chr2:153191000-153191200	Enhancers	Cortex derived primary cultured neurospheres	brain
35	chr2:153191000-153191200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr2:153191000-153191200	Enhancers	Liver	Liver
37	chr2:153191000-153191200	Bivalent Enhancer	Brain Germinal Matrix	brain
38	chr2:153191000-153191200	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
39	chr2:153191000-153191200	Flanking Active TSS	Brain Substantia Nigra	brain
40	chr2:153191000-153191200	Enhancers	Fetal Intestine Large	intestine
41	chr2:153191000-153191200	Enhancers	Fetal Lung	lung
42	chr2:153191000-153191200	Flanking Active TSS	A549	lung
43	chr2:153191000-153191200	Enhancers	HSMMtube	muscle
44	chr2:153191000-153191200	Enhancers	HUVEC	blood vessel
45	chr2:153191000-153191200	Enhancers	NH-A	brain
46	chr2:153191000-153191200	Enhancers	Osteobl	bone
47	chr2:153191000-153191400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr2:153191000-153191400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
49	chr2:153191000-153191400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr2:153191000-153191400	Flanking Active TSS	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links